Omeros Corporation
OMER
#6795
Rank
โ‚น56.14 B
Marketcap
โ‚น791.90
Share price
-4.73%
Change (1 day)
22.87%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -โ‚น10.33 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น14.28 Billion a decrease over its 2023 earnings that were of -โ‚น13.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.33 Billion-27.66%
2024 -โ‚น14.28 Billion9.63%
2023 -โ‚น13.02 Billion-9.57%
2022 -โ‚น14.4 Billion-30.65%
2021 -โ‚น20.76 Billion86.28%
2020 -โ‚น11.15 Billion99.45%
2019 -โ‚น5.59 Billion-49.91%
2018 -โ‚น11.16 Billion190.77%
2017 -โ‚น3.84 Billion-27.96%
2016 -โ‚น5.33 Billion-17.61%
2015 -โ‚น6.47 Billion1.88%
2014 -โ‚น6.35 Billion87.56%
2013 -โ‚น3.39 Billion
2011 -โ‚น2.48 Billion-8.96%
2010 -โ‚น2.73 Billion45.03%
2009 -โ‚น1.88 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น0.86 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚น0.35 Billion-96.77%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
โ‚น1.070 T-10,014.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.926 T-27,200.33%๐Ÿ‡บ๐Ÿ‡ธ USA